
The Federal Trade Commission (FTC) is reportedly set to greenlight ExxonMobil’s $64 billion acquisition of Texas-based petroleum producer Pioneer Resources. However, amidst antitrust concerns, a key executive, Scott Sheffield, is anticipated to be excluded from serving on Exxon’s board.
According to sources familiar with the matter, the FTC’s approval is contingent upon Sheffield, Pioneer’s founder and former CEO, not assuming a position on Exxon’s board. This decision stems from Sheffield’s involvement in a price-fixing lawsuit, where Pioneer and other regional producers face accusations of collusion with OPEC to restrict oil supplies. Although Sheffield has not been implicated in any wrongdoing, the FTC is wary of potential anticompetitive behavior if he were to remain within the company post-acquisition.
Related: Exxon and Enbridge Face Antitrust Lawsuit Over Alleged Market Exclusion Tactics
The allegations of energy price-fixing, though not yet substantiated, hold significant political ramifications. Critics argue that any concrete evidence would undercut Republican claims that President Joe Biden’s energy policies are driving up fuel costs for consumers. However, companies named in the lawsuit, including Pioneer, Diamondback Energy, and Hess Corp., vehemently deny these accusations, asserting their innocence in responding to the class-action claims.
Source: Politico
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas